Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-4055 in Advanced Colorectal Cancer
NCT00498407Phase 2Completed
- Sponsor
- Clavis Pharma
- Start
- May 2007
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of elacytarabine in colorectal cancer (CRC), sponsored by Clavis Pharma. Started May 2007; status: completed.
02
Drugs
elacytarabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00498407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498407.